Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Managed Care Pharmacy : JMCP|February 6, 2010
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxisMichael P Frogel, Dan L Stewart, Michael Hoopes, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 10, 2016
Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeonIan S Mutchnick, Meena A Thatikunta, William C Gump, et al.BMC Infectious Diseases|July 23, 2013
Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysisDan L Stewart, Kellie J Ryan, Jerry G Seare, et al.Current Medical Research and Opinion|October 1, 2009
Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attentionDan L Stewart, José R Romero, Erin K Buysman, et al.Pediatrics|May 8, 2023
Use of Point-of-Care Ultrasonography in the NICU for Diagnostic and Procedural PurposesDan L Stewart, Yasser Elsayed, María V Fraga, et al.Clinical Therapeutics|March 1, 2011
Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infantsJosé R Romero, Dan L Stewart, Erin K Buysman, et al.European Journal of Clinical Pharmacology|March 23, 2010
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)Robert M Ward, Brinda Tammara, Sandra E Sullivan, et al.Infection Control and Hospital Epidemiology|March 4, 2022
SHEA Neonatal Intensive Care Unit (NICU) White Paper Series: Practical approaches for the prevention of central-line-associated bloodstream infectionsMartha Muller, Kristina A Bryant, Claudia Espinosa, et al.Digestive Diseases and Sciences|July 8, 2010
Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux diseaseJaroslaw Kierkus, Wanda Furmaga-Jablonska, Janice E Sullivan, et al.CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term InfantsJacqueline G Gerhart, Kevin M Watt, Andrea Edginton, et al.Pageof 3